Company registration number: 06911544
Unaudited financial statements
for the year ended 31 March 2025
for
Core Pharma Limited
Pages for filing with the Registrar
Company registration number: 06911544
Core Pharma Limited
Balance sheet
as at 31 March 2025
2025 2024
Note £ £ £ £
Fixed assets
Intangible assets 4 - -
Tangible assets 5 2,623 3,911
2,623 3,911
Current assets
Stocks 42,286 41,914
Debtors 328,308 381,439
Cash at bank and in hand 56,788 38,623
427,382 461,976
Creditors: amounts falling due within one
year 		(79,492) (104,249)
Net current assets 347,890 357,727
Total assets less current liabilities 350,513 361,638
Creditors: Amounts falling due after more
than one year 		(4,500) (14,827)
Provisions for liabilities (2,748) (2,748)
NET ASSETS 343,265 344,063
Capital and reserves
Called up share capital 2 2
Profit and loss account 343,263 344,061
TOTAL EQUITY 343,265 344,063
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 March 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 06911544
Core Pharma Limited
Balance sheet - continued
as at 31 March 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
These financial statements were approved by the Board of directors and authorised for issue on 5 December 2025 and signed on its behalf by:
Mrs V Gaines, Director Mrs F Kerry, Director
5 December 2025 Date:
2
Core Pharma Limited
Notes to the financial statements
for the year ended 31 March 2025
1 Company information
Core Pharma Limited is a private company registered in England and Wales. Its registered number is 06911544. The company is limited by shares. Its registered office is 1A Church Street, Houghton le Spring, Tyne and Wear, DH4 4DN.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Amortisation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Goodwill -
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and Equipment:
Plant and machinery -
Plant and Equipment - 10% straight line
Motor Vehicles - 25% reducing balance
3
Core Pharma Limited
Notes to the financial statements - continued
for the year ended 31 March 2025
2 Accounting policies - continued
Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that been enacted or substantively enacted by the balance sheet date and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probably that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Government grants
Government Grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching them and the grants will be received using the accrual model.
3 Average number of employees
During the year the average number of employees was 9 (2024 - 9).
4 Intangible assets
Goodwill
£
Cost
At 1 April 2024 7,171
At 31 March 2025 7,171
4
Core Pharma Limited
Notes to the financial statements - continued
for the year ended 31 March 2025
4 Intangible assets - continued
Amortisation
At 1 April 2024 7,171
At 31 March 2025 7,171
Net book value
At 31 March 2025 -
At 31 March 2024 -
5 Tangible fixed assets
Plant and
Equipment
£
Cost
At 1 April 2024 56,111
At 31 March 2025 56,111
Depreciation
At 1 April 2024 52,200
Charge for year 1,288
At 31 March 2025 53,488
Net book value
At 31 March 2025 2,623
At 31 March 2024 3,911
5